0+
Active Patients
0+
Specialists
0+
Collaborating
Physicians
0+
Researchers
>$0M
Research Funding
(2013–present)
Nobel-Prize-Award-2-2048x1365

Award-winning Research

From a first-in-class kidney cancer drug to the development of new surgical and radiation approaches, a uniquely collaborative environment catalyzes transformative research.

Recognized by the National Cancer Institute with a prestigious Specialized Program of Research Excellence (SPORE) Award along with the Harvard Cancer Center.

Recognized by DCEO Magazine and Dallas Innovates for its innovation and transformational creativity as a finalist for the inaugural 2020 Healthcare Innovation Award.

Bruce Beutler, M.D.

One of only two programs in the country developing the next generation of immunotherapies with a Nobel Prize-winning immunologist.

robotic surgery

Expertise Improving Survival

Expertise attested by survival rates that exceed national averages stage for stage.

Patient survival rates three times higher for stage 4 kidney cancer and exceeding national benchmarks across all stages.

Recognized with a Leaders in Clinical Excellence Program Award, the Kidney Cancer Program is setting new standards in cancer care.

image-belonging

Belonging

Supportive care and services helping patients navigate the cancer landscape while creating a sense of community.    

Dedicating their time and sharing their experiences, our patient and caregiver volunteers set the tone. 

Promoting educational activities to increase awareness about kidney cancer.